BS Views: Pandemic withdrawal symptoms

Here are the top BS Opinion articles of the day

News that Serum Institute and Bharat Biotech have diverted some of their Covid-19 vaccination lines for other products is concerning. The Omicron variant, though less harmful than the Delta version, has proved dangerous for the unvaccinated. In other words, it is vital that the government’s attention is not deflected by falling caseloads. In fact, as the top edit points out, it is important for it to focus on sustaining and expanding the programme for booster doses and to rely on science- and data-based decision-making in managing the pandemic. Read it here

In other views:

The second edit explains how and why India can become a reliable grain exporter. Read it here

Shyam Ponappa argues that less restrictive regulations with better process discipline could improve broadband reach and functionality. Read it here

Nivedita Mookerjee explores the question of why some marque brands have left India and some unlikely ones have stuck on. Read it here

QUOTE OF THE DAY

‘We should be operating EBITDA breakeven in next six quarters well ahead of estimates by most analysts’

Paytm founder and CEO Vijay Shekhar Sharma to shareholders